Ferhan Qureshi
Overview
Explore the profile of Ferhan Qureshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oechtering J, Schaedelin S, Stein K, Maceski A, Melie-Garcia L, Benkert P, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Jan;
12(2):e200361.
PMID: 39752618
Background And Objectives: Levels of activated complement proteins in the CSF are increased in people with multiple sclerosis (MS) and are associated with clinical disease severity. In this study, we...
2.
Schoeps V, Bhargava P, Virupakshaiah A, Ladakis D, Moseley C, Chong J, et al.
J Neurol Neurosurg Psychiatry
. 2024 Sep;
96(2):150-157.
PMID: 39266284
Background: Lipids are of particular interest for the study of neuroinjury and neuroinflammation as structural lipids are major components of myelin, and a variety of lipid species modulate inflammation. In...
3.
Jakimovski D, Zivadinov R, Qureshi F, Ramanathan M, Weinstock-Guttman B, Tavazzi E, et al.
Biomolecules
. 2024 Jul;
14(7).
PMID: 39062538
Increased choroid plexus (CP) volume has been recently implicated as a potential predictor of worse multiple sclerosis (MS) outcomes. The biomarker signature of CP changes in MS are currently unknown....
4.
Jakimovski D, Qureshi F, Ramanathan M, Keshavan A, Leyden K, Jalaleddini K, et al.
Mult Scler Relat Disord
. 2024 May;
87:105687.
PMID: 38776599
Background: Brain hypoperfusion is linked with worse physical, cognitive and MRI outcomes in multiple sclerosis (MS). Understanding the proteomic signatures related to hypoperfusion could provide insights into the pathophysiological mechanism....
5.
Chitnis T, Qureshi F, Gehman V, Becich M, Bove R, Cree B, et al.
Nat Commun
. 2024 May;
15(1):4297.
PMID: 38769309
The multifaceted nature of multiple sclerosis requires quantitative biomarkers that can provide insights related to diverse physiological pathways. To this end, proteomic analysis of deeply-phenotyped serum samples, biological pathway modeling,...
6.
Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation
Jakimovski D, Qureshi F, Ramanathan M, Jalaleddini K, Ghoreyshi A, Dwyer M, et al.
J Neurol Sci
. 2024 May;
461:123055.
PMID: 38761669
Background: Atrophied lesion volume (aLV), a proposed biomarker of disability progression in multiple sclerosis (MS) and transition into progressive MS (PMS), depicts chronic periventricular white matter (WM) pathology. Meningeal infiltrates,...
7.
Jalaleddini K, Bermel R, Talente B, Weinstein D, Qureshi F, Rasmussen M, et al.
Mult Scler
. 2024 Feb;
30(3):432-442.
PMID: 38374525
Objectives: We evaluate the potential clinical and cost impacts of discontinuing disease-modifying therapy (DMT) in people with multiple sclerosis (PwMS) when age-related immunosenescence can reduce DMT efficacy while increasing associated...
8.
Oechtering J, Stein K, Schaedelin S, Maceski A, Orleth A, Meier S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Feb;
11(2):e200212.
PMID: 38354323
Background And Objectives: Histopathologic studies have identified immunoglobulin (Ig) deposition and complement activation as contributors of CNS tissue damage in multiple sclerosis (MS). Intrathecal IgM synthesis is associated with higher...
9.
Jalaleddini K, Jakimovski D, Keshavan A, McCurdy S, Leyden K, Qureshi F, et al.
Ann Clin Transl Neurol
. 2024 Jan;
11(3):729-743.
PMID: 38234075
Background: A quantitative measurement of serum proteome biomarkers that would associate with disease progression endpoints can provide risk stratification for persons with multiple sclerosis (PwMS) and supplement the clinical decision-making...
10.
Zhu W, Chen C, Zhang L, Hoyt T, Walker E, Venkatesh S, et al.
Brain Commun
. 2024 Jan;
6(1):fcad300.
PMID: 38192492
Few studies examined blood biomarkers informative of patient-reported outcome (PRO) of disability in people with multiple sclerosis (MS). We examined the associations between serum multi-protein biomarker profiles and patient-reported MS...